1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. Pennsylvania >
  6. Zelira Therapeutics Acquires Ilera Therapeutics

M&A Deal Summary

Zelira Therapeutics Acquires Ilera Therapeutics

On October 9, 2019, Zelira Therapeutics acquired life science company Ilera Therapeutics

Acquisition Highlights
  • This is Zelira Therapeutics’ 1st transaction in the Life Science sector.
  • This is Zelira Therapeutics’ 1st transaction in the United States.
  • This is Zelira Therapeutics’ 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2019-10-09
Target Ilera Therapeutics
Sector Life Science
Buyer(s) Zelira Therapeutics
Deal Type Merger

Target

Ilera Therapeutics

Pennsylvania, United States
Ilera Therapeutics LLC is a US-based company established by a team of experienced executives in the global biopharmaceutical sector. Ilera Therapeutics LLC is based in Pennsylvania and engaged in the development and formulation of proprietary, branded cannabis products, and cannabinoids science focused on targeted medical and other indications.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Zelira Therapeutics

Perth, Australia
Category Company
Founded 2003
Sector Life Science
Revenue 940K AUD (2024)
DESCRIPTION

Zelira Therapeutics is a biopharmaceutical company developing proprietary cannabinoid formulations to treat a variety of medical conditions. Zelira Therapeutics is based in Perth, Australia.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: Pennsylvania M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal